Target
Beta-2 adrenergic receptor
Ligand
BDBM50213113
Substrate
n/a
Meas. Tech.
Beta-2 AR binding assay
Ki
>100000000±n/a nM
Citation
 Wainer, IWBernier, MToll, LRJimenez, LA Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas US Patent  US10617654 Publication Date 4/14/2020 
Target
Name:
Beta-2 adrenergic receptor
Synonyms:
ADRB2 | ADRB2R | ADRB2_HUMAN | B2AR | Beta-2 adrenoceptor | Beta-2 adrenoreceptor
Type:
n/a
Mol. Mass.:
46461.69
Organism:
Homo sapiens (Human)
Description:
P07550
Residue:
413
Sequence:
MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
  
Inhibitor
Name:
BDBM50213113
Synonyms:
(S,R)-(+)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl]-1,3-benzenediol | CHEMBL229616 | US10617654, Compound (S,R)-6
Type:
Small organic molecule
Emp. Form.:
C14H23NO3
Mol. Mass.:
253.3373
SMILES:
CCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1
Structure:
Search PDB for entries with ligand similarity: